Journal Article Summary
The article investigates the use of lamotrigine, a medication typically used for epilepsy and bipolar disorder, in treating mood disorders among adolescents. This topic is important because mood disorders in young people can lead to serious consequences, including suicide and long-term mental health issues. Despite some existing research on lamotrigine's effectiveness, concerns about side effects, particularly the risk of serious skin rashes, have limited its use in this population.
The researchers conducted a retrospective review of medical charts for 42 adolescents who were treated with lamotrigine for mood disorders across three clinical sites. They assessed the effectiveness of the treatment by comparing scores on the Clinical Global Impression (CGI) scale at the beginning and end of treatment. The findings showed that over half of the participants experienced improvement in their mood symptoms, with a notable decrease in CGI scores. However, the study also highlighted that some patients developed benign rashes as a side effect of the medication.
While the study suggests that lamotrigine may be beneficial for adolescents with mood disorders, it has limitations, including its retrospective nature and the small sample size. Patients and caregivers should be aware of the potential for side effects, such as rashes, and discuss these findings with a healthcare professional before starting treatment. It is crucial to weigh the benefits and risks of lamotrigine in the context of individual health needs and to consider ongoing monitoring during treatment.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Carandang Carlo, Robbins Douglas, Mullany Elizabeth, Yazbek Monique, Minot Sara. Lamotrigine in Adolescent Mood Disorders: A Retrospective Chart Review. Journal of the Canadian Academy of Child and Adolescent Psychiatry 2007. PMID: 18392173. PMCID: PMC2276172.
Featured Pill Pals Product
Benztropine 0.5 mg Tablets --- Generic For Cogentin --- Leading Pharma
Benztropine 0.5 mg Tablets — Generic For Cogentin — Leading Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
